Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: From the German and Swiss Lung Cancer Study Group

Journal of Clinical Oncology

Volumn 22, Issue 12, 2004, Pages 2348-2356

  Laack, E ^a   Dickgreber, N ^a   Muller T ^a   Knuth, A ^a   Benk, J ^a   Lorenz, C ^a   Gieseler, F ^a   Durk H ^a   Engel Riedel, W ^a   Dalhoff, K ^a   Kortsik, C ^a   Graeven, U ^a   Burk, M ^a   Dierlanim, T ^a   Welte, T ^a   Burkholder, I ^a   Edler, L ^a   Hossfeld, D K ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; VINBLASTINE;

ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMATOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PHASE 3 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TIME SERIES ANALYSIS; TOXICITY; ADOLESCENT; ADULT; AGED; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; HEMATOLOGIC DISEASE; LUNG TUMOR; MIDDLE AGED; MULTICENTER STUDY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; HEMATOLOGIC DISEASES; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; QUALITY OF LIFE; SURVIVAL RATE; VINBLASTINE;

EID: 2942731677     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.10.576     Document Type: Article

References (24)

1. Bunn PA Jr, Kelly K: New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions. Clin Cancer Res 5:1087-1100, 1998
2. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-Small Cell Lung Cancer Collaborative Group. BMJ 311:899-909, 1995
3. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 346:92-98, 2002
4. Le Chevalier T, Brisgand D, Douillard JY, et al: Randomised study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-368, 1994
5. Manegold C: Single-agent gemcitabine versus cisplatin/etoposide in patients with inoperable, locally advanced, or metastatic non-small cell lung cancer. Semin Oncol: 25:18-22. 1998
6. Perng RP, Chen YM, Ming-Liu JM, et al: Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small cell lung cancer in a phase II randomized study. J Clin Oncol 15:2097-2102, 1997
7. Aapro MS, Martin C, Hatty S: Gemcitabine - a safety overview. Anticancer Drugs 9:191-201, 1998
8. Johnson SA, Harper P, Hortobagyi GN, et al: Vinorelbine: An overview. Cancer Treat Rev 22:127-142, 1996
9. Isokangas OP, Knuuttila A, Halme M, et al: Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small cell lung cancer. Ann Oncol 10:1059-1063, 1999
10. Bajetta E, Chiara Stani S, De Candis D, et al: Gemcitabine plus vinorelbine as first-line chemotherapy in advanced non-small cell lung carcinoma: A phase II trial. Cancer 89:763-768, 2000
11. Lilenbaum R, Cano R, Schwartz M, et al: Gemcitabine and vinorelbine in advanced non-small cell lung carcinoma: A phase II study. Cancer 88:557-562. 2000
12. Chen YM, Perng RP, Yang KY, et al: A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer. Chest 117:1583-1589, 2000
13. Krajnik G, Mohn-Staudner A, Thaler J, et al: Vinorelbine-gemcitabine in advanced non-small cell lung cancer (NSCLC): An AASLC phase II trial. Ann Oncol 11:993-998, 2000
14. Laack E, Mende T, Benk J, et al: Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: A phase II trial. Eur J Cancer 37:583-590, 2001
15. Gridelli C, Perrone F, Gallo C, et al: Chemotherapy for elderly patients with advanced non-small lung cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer lnst 95:362-372, 2003
16. Frasci G, Lorusso V, Panza N, et al: Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small cell lung cancer. J Clin Oncol 18:2529-2536, 2000
17. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
18. rd edition. European Organisation for Research and Treatment of Cancer, Brussels, Belgium, 2001
19. Lilenbaum RC, Herndon J, List M, et al: Single-agent (SA) versus combination chemotherapy (CC) in advanced non-small cell lung cancer (NSCLC): a CALGB randomized trial of efficacy, quality of life (QOL), and costeffectiveness. Proc Am Soc Clin Oncol 21:1, 2002 (abstr 2)
20. Van Meerbeeck JP, Smit E, Lianes P, et al: An EORTC randomized phase III trial of three chemotherapy regimens in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 20:308, 2001 (abstr 1228)
21. Georgoulias V, Papadakis E, Alexopoulos A, et al: Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: A randomised multicentre trial. Lancet 357:1478-1484, 2001
22. Vansteenkiste JF, Vandebroek JE, Nackaerts KL, et al: Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine. Ann Oncol 12:1221-1230, 2001
23. Alberola V, Camps C, Provencio M, et al: Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: A Spanish lung cancer group phase III randomized trial. J Clin Oncol 21:3207-3213, 2003
24. Gridelli C, Gallo C, Shepherd FA, et al: Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small cell lung cancer: A phase III trial of the Italian GEMVIN investigators and the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 21:3025-3034, 2003